Isofol Medical AB (publ) publishes annual report and corporate governance report for 2022
GOTHENBURG, Sweden, April 6, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company's annual report and corporate governance report for the financial year 2022 are now available, in Swedish, on the company's website, www.isofolmedical.com.The information in the press release is intended for investors. For further information, please contact Isofol Medical AB (publ)Thomas Andersson, Chief Executive Officer E-mail: thomas.andersson@isofolmedical.comPhone: +46 (0) 709 44 00 93 Roy Jonebrant, Chief Financial Officer E-mail: roy.jonebrant@